Cristina Larkin has sold SPRO and made no open-market buys since Jul 2018
COO at Spero Therapeutics, Inc.
SEC CIK 0001721173 · Filings on SEC.gov ↗
$0Bought
$298KSold
NoneLast buy
Every filing
2 filings since Jul 2018, newest first
Filings come from SEC EDGAR. Not investment advice.